Clinical trial
The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation…
NCT00126802 · AHS Cancer Control Alberta, Other · Unknown status
Key facts
| NCT number | NCT00126802 |
|---|---|
| Title | The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer |
| Official title | The Role of Tomotherapy (Dynamic IMRT and Megavoltage CT Scanning) in Hypofractionated/Dose Escalated Conformal Radiation Treatment Using Magnetic Resonance Spectroscopy (MRS) Scans to Predict and Document the Pattern of Local Failure for High Risk Prostate Cancer |
| Lead sponsor | AHS Cancer Control Alberta, Other |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Procedure |
| Interventions | Tomotherapy |
| Enrollment | 60 |
| Start date | Apr 1, 2005 |
| Primary completion | Mar 1, 2017 |
| Completion | Mar 1, 2017 |
| First posted | Aug 5, 2005 |
| Last update posted | Jul 6, 2016 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: